161 – 170 of 322
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Assessment of health-related quality of life in patients with severe haemophilia with reduced bone density
- Contribution to journal › Published meeting abstract
-
Mark
Factor VIII light chain mutations and cysteine substitutions predispose for inhibitor development in mild and moderate haemophilia A: first results from the INSIGHT study
- Contribution to journal › Published meeting abstract
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
- Contribution to journal › Scientific review
-
Mark
A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A: the ESPRIT study
(2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.29-30
- Contribution to journal › Published meeting abstract
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
Ljung, Rolf LU
; Knobe, Karin
LU
; Sjörin, Elsy
LU
; Nilsson, D.
and Hallden, C.
(2010)
In Haemophilia
16.
p.93-93
- Contribution to journal › Published meeting abstract
-
Mark
Management of bleedings in carriers
- Contribution to journal › Published meeting abstract
-
Mark
A retrospective study: of Octaplex (R) in the treatment of bleeding in patients with haemophilia A complicated by inhibitors
- Contribution to journal › Published meeting abstract
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
- Contribution to journal › Published meeting abstract
-
Mark
Clinical issues in inhibitors
- Contribution to journal › Scientific review
-
Mark
Von Willebrand disease prophylaxis network
- Contribution to journal › Published meeting abstract